NASTRAN HASHEMI: Open Payments
NPI 1891009163 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 19 payments from 11 companies in 2025. Trend: 2023 $619 · 2024 $501 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 5 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| DJO, LLC | 2 | $76 |
| Grifols USA, LLC | 2 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Smith+Nephew, Inc. | 2 | $47 |
| Electromed, Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| ABBVIE INC. | 1 | $33 |
Products named: OFEV, Ozempic, BIOSKIN, AIRCAST, Prolastin-C Liquid, FARXIGA, SMARTVEST, NUCALA.
Industry payments across CA — which companies pay providers there.
